Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayers

Showing results (561-570 of 690) with videos related to

Pageof 69
Sort By:
The Journal of Infectious Diseases|January 19, 2007
HIV-1 drug resistance in variants from the female genital tract and plasmaKimdar Sherefa Kemal, Harold Burger, Douglas Mayers, et al.
Viruses|February 28, 2023
SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 PatientsLuke Gerla, Subhabrata Moitra, Desmond Pink, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.
Nature Communications|August 1, 2013
Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cellsSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Vaccine|December 24, 2023
In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDVSahar Mahmood, Paul Skinner, Caroline J Warren, et al.
Virology|June 20, 1995
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptaseR W Buckheit, V Fliakas-Boltz, S Yeagy-Bargo, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsD L Mayers, J A Mikovits, B Joshi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
JAMA|March 3, 1989
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug usersP A Selwyn, E E Schoenbaum, K Davenny, et al.
Pageof 69

Showing results (561-570 of 690) with videos related to

Sort By:
Pageof 69
The Journal of Infectious Diseases|January 19, 2007
HIV-1 drug resistance in variants from the female genital tract and plasmaKimdar Sherefa Kemal, Harold Burger, Douglas Mayers, et al.
Viruses|February 28, 2023
SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 PatientsLuke Gerla, Subhabrata Moitra, Desmond Pink, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupA J Japour, D L Mayers, V A Johnson, et al.
Nature Communications|August 1, 2013
Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cellsSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Vaccine|December 24, 2023
In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDVSahar Mahmood, Paul Skinner, Caroline J Warren, et al.
Virology|June 20, 1995
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptaseR W Buckheit, V Fliakas-Boltz, S Yeagy-Bargo, et al.
AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsD L Mayers, J A Mikovits, B Joshi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.
JAMA|March 3, 1989
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug usersP A Selwyn, E E Schoenbaum, K Davenny, et al.
Pageof 69